Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS, FVT

Quorum Review IRB and Kinetiq to Celebrate eConsent Product Launch, Present Sessions at DIA 2017


SEATTLE, June 15, 2017 /PRNewswire/ -- Quorum Review IRB will celebrate the launch of Q Consenttm, the new standard in electronic informed consent, at DIA 2017 in booth #2212. Kinetiq, the consulting and technology division of Quorum, also will be featured in two sessions at next week's DIA conference with topics that range from emerging trends to best practices in clinical research.

Quorum Review IRB is the first name in streamlined, service-centered independent ethics and regulatory review. Quorum assures the ethical integrity of clinical research. We help our partners advance the frontiers of medical innovation with greater confidence and control while sustaining the rights, dignity and safety of participants. Beyond traditional institutional review board services, Quorum offerings include single IRB (sIRB) services for institutions and IRB-integrated eConsent. (PRNewsfoto/Quorum Review IRB)

"As always, we look forward to presenting our subject matter expertise on topics that positively impact the clinical research community," says Quorum CEO Cami Gearhart. "Our mission at Quorum is to move research forward together, and our Q Consent tool will help researchers and sponsors move forward with a new standard in consenting. We invite DIA attendees to visit us, celebrate our launch, and find out why secure electronic informed consent is now easy and affordable."

Breakout Sessions

Kinetiq Regulatory Attorney Aarthi B. Iyer will present regulatory insights in an informative session on postmarketing safety studies. Study sponsors and CROs will learn how to maximize the impact of postmarketing studies and achieve effective execution and compliance. This session takes place on Monday, June 19 at 11:00 a.m.

James Riddle, Vice President of Client Services for Kinetiq, will be featured in a breakout session, where he and representatives from HHS will discuss the new Common Rule and its impact on sponsors and CROs. This session is scheduled for Wednesday, June 21 at 2:00 p.m.

Celebrate Q Consent

Visit Quorum and Kinetiq in the exhibit hall on Monday, June 19 at 4:45 p.m. at booth 2212, where Quorum will host a champagne toast to celebrate the launch of the revolutionary eConsent solution: Q Consent.

About Quorum Review IRB
Discover more at our website.

About Kinetiq
Discover more at our website.

Contact:

Scott Smith
Director of Marketing
(206) 448-4082
[email protected]

 


Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subject protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies?as well as others around the world?to develop contemporary approaches to a changing landscape.

SOURCE Quorum Review IRB


These press releases may also interest you

at 07:05
Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the first quarter ended March 31, 2024. All...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it has been selected as the winner of the "Best Overall Mental Health Solution" award in the eighth annual MedTech...

at 07:05
REGENXBIO Inc. today announced it will participate in the following upcoming investor conferences: BofA Securities Health Care Conference 2024Fireside Chat: Wednesday, May 15, 2024 at 2:20 p.m. ETLocation: Las Vegas, NV Stifel 2024 Tailoring Genes...

at 07:00
The Canadian Armed Forces (CAF) has announced its selection of Delta Development Team, Inc. to provide innovative products aimed at bolstering the medical capacity of frontline troops. This significant decision underscores Canada's commitment to...

at 07:00
CareRx Corporation ("CareRx" or the "Company") , Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the first quarter ended March 31, 2024. "Our first...

at 06:50
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today...



News published on and distributed by: